Trials / Completed
CompletedNCT00331240
24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 29 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | travoprost/timolol fixed combination | |
| DRUG | placebo (artificial tears) |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2007-01-01
- Completion
- 2007-02-01
- First posted
- 2006-05-29
- Last updated
- 2014-05-12
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00331240. Inclusion in this directory is not an endorsement.